When was Onc.ai founded?

Onc.ai was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is Onc.ai located?

Onc.ai is headquartered in San Carlos, United States.

How many employees does Onc.ai have?

As of Sep 30, 2026, the latest employee count at Onc.ai is 25.

Is Onc.ai a funded company?

Onc.ai is a funded company, having raised a total of $31M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 02, 2020.

When was the latest funding round of Onc.ai?

Onc.ai's latest funding was a $***** Grant (prize money) round on Aug 04, 2025, with participation from 1 investor.

Where does Onc.ai rank among its competitors?

Onc.ai ranks 11th amongst 305 active competitors, of which 85 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was DeepWise, which secured an undisclosed amount in Jun, 2026.

Who are the top competitors of Onc.ai?

Onc.ai's top competitors include PathAI, Aiforia and Median Technologies. Among them, DeepWise secured the most recent funding round in June, 2026.

Onc.ai - 2026 Company Profile, Team, Funding & Competitors

Onc.ai is a series A company based in San Carlos (United States), founded in 2020 by Akshay Nanduri and Petr Jordan. It operates as an AI-based cancer treatment and diagnosis platform for healthcare providers. Onc.ai has raised $31M in funding from investors like MassMutual, Accomplice and Action Potential Venture Capital. The company has 305 active competitors, including 85 funded and 17 that have exited. Its top competitors include companies like PathAI, Aiforia and Median Technologies.

Company Details

AI-based cancer treatment and diagnosis platform for healthcare providers. The platform assists in the decision-making process for providing and aiding in cancer treatment decisions using AI technology, genomics, proteomics, radionics, and more.

Key Metrics

Founded Year

2020

Location

San Carlos, United States

Stage

Series A

Total Funding

$31M in 4 rounds

Latest Funding Round

Grant (prize money), Aug 04, 2025, $*****

Investors

MassMutual & 13 more

Ranked

11^th among 305 active competitors

Employee Count

25 as on Sep 30, 2026

Similar Companies

OpenEvidence & 3087 more

View Onc.ai's full profile

Onc.ai has raised a total funding of $31M over 4 rounds. Its first funding round was on Dec 02, 2020. Its latest funding round was a Grant (prize money) round on Aug 04, 2025 for $*****. 1 investor participated in its latest round. Onc.ai has 10 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Onc.ai:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 04, 2025	2054275	Grant (prize money)	3412204	6035551	2374158	3483935
Sep 13, 2024	7181860	Grant (prize money)	3874853	9836195	7200720	HHS
Jan 05, 2023	1796089	Series A	8868378	5291887	MassMutual & 1 more	Life Extension Ventures & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Onc.ai's funding rounds and investors

The founders of Onc.ai are Akshay Nanduri and Petr Jordan.

Here are the details of Onc.ai's key team members:

Akshay Nanduri: Founder & CEO of Onc.ai and founder of 1 other company.
Contact Info: 3 email addresses
Petr Jordan: CTO, Founding Team Member of Onc.ai.
Contact Info: 1 email address

View details of Onc.ai's Founder profiles and Board Members

Onc.ai's employee count trend

Onc.ai has 25 employees as of Sep 26. Here is Onc.ai's employee count trend over the years:

Uncover Onc.ai's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Onc.ai include PathAI, Aiforia and Median Technologies. Here is the list of Top 10 competitors of Onc.ai, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, General Atlantic & 22 others	72/100
2nd	Aiforia 2014, Helsinki (Finland), Public	Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas	$23M	Ascend Capital Partners, Businessfinland & 8 others	66/100
3rd	Median Technologies 2002, Valbonne (France), Public	Developer of medical imaging software for clinical trials and diagnostics	$5.28M	Matignon Finances, Lion Point Life Science Partners ... & 13 others	62/100
4th	Proscia 2014, Philadelphia (United States), Acquired	Provider of an AI and cloud-based digital pathology solution for cancer diagnosis	$129M	Triangle Peak Partners, TEDCO & 22 others	62/100
5th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$50.4M	ARUP Laboratories, Zoetis & 2 others	62/100
6th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	61/100
7th	Avenda Health 2017, Santa Monica (United States), Series B	Developer of a focal therapy system to treat prostate cancer	$31M	VCapital, Plug and Play Tech Center & 3 others	61/100
8th	Aignostics 2018, Berlin (Germany), Series B	Developer of artificial intelligence software for biomedical image analysis applications	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	61/100
9th	DeepWise 2017, Beijing (China), Series D	Developer of AI-based radiology image solutions primarily for cancer diagnosis	$115M	Legend Capital, CICC Capital & 18 others	59/100
10th	Mindpeak 2017, Hamburg (Germany), Series A	Provider of AI-based pathological analysis platform	$18.3M	IFB Innovationsstarter, ZEISS & 28 others	59/100
11th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	Accomplice, MassMutual & 12 others	57/100